Research Article | OPEN ACCESS
Possible Reversal of Sodium Arsenate-induced Liver Toxicity by Hexane Leaf Extract of Alchornea laxiflora
Uhunmwangho S. Esosa, Omage Kingsley, Erifeta O. Georgina, Josiah J. Sunday and Nwangwu C.O. Spencer
Department of Biochemistry, College of Basic Medical Sciences,
Igbinedion University, Okada, Edo State, Nigeria
Asian Journal of Medical Sciences 2013 1:03-08
Received: July 24, 2012 | Accepted: August 28, 2012 | Published: February 25, 2013
Abstract
This research was aimed at evaluating the anti-toxicity potentials or properties of A. laxiflora. Thus, the possible reversing effect of sodium arsenate-induced liver toxicity by hexane leaf extract of Alchornea laxiflora was investigated using adult wistar albino rats weighing between 150-200 g as experimental model. Oral administration of the extract at varying doses (0.5, 1.0, 5.0 and 10.0 mg/kg body weight) was shown to significantly (p<0.05) decrease the effect of sodium arsenate-induced liver damage by reducing the activities of AST, ALT, ALP, GGT and TB, both in the serum and liver homogenate. Pre-treatment with the extract prior to the intra-peritoneal administration of the toxicant (sodium arsenate) at a dose of 2 mg/kg body weight was shown to be more effective at reversing the effect of the toxicant than post-treatment with the extract after intoxication. Thus, the ability of Alchornea laxiflora leaf extract to protect against sodium arsenate induced liver damage by possible reversal of arsenic toxicity suggests that this plant extract might be suitable for the treatment of sodium arsenate toxicity.
Keywords:
Alchornea laxiflora, hexane, liver homogenate, serum enzymes, sodium arsenate, toxicity,
Competing interests
The authors have no competing interests.
Open Access Policy
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Copyright
The authors have no competing interests.
|
|
|
ISSN (Online): 2040-8773
ISSN (Print): 2040-8765 |
|
Information |
|
|
|
Sales & Services |
|
|
|